NL-OMON42385已完成不适用
Initial Immune Response to New Biomaterials - Immune Response to Biomaterials
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 4
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Male persons
- •Feeling physically healthy, defined as not having fever or flu-like symptoms.
排除标准
- •Known infectious / genetic diseases, which could affect the immune system
研究者
相似试验
已完成
2 期
Immune responses of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike (NDV-HXP-S) with heterologous booster after 12 months in adultsTCTR20230809003ational Research Council of Thailand (NRCT)130
已完成
Unknown
Investigation of cell mediated immune response induced by varicella vaccinePrevention of herpes zosterJPRN-jRCT1080223477The Research Foundation for Microbial Diseases of Osaka University80
已完成
不适用
In vitro characterization of the immune response of recovered COVID-19 patients and healthy controls to SARS-CoV-2.CoronaCOVID-19SARS-CoV-210047438NL-OMON50131ISA Pharmaceuticals B.V.14
Unknown
不适用
Feasibility 'innate' allogeneic stem cells transplantioHematological malignancies (hematologische maligniteiten)Allogeneic stem cells transplantation (allogene stamcel transplantatie)Innate immune system (aangeboren immuunsysteem)NL-OMON25484MC UtrechtHeidelberglaan 1003584 CX Utrecht35
已完成
不适用
Prospective study on early immune response to factor VIII exposure in previously untreated patients with severe hemophilia ABleeding disorderHaemophilia A10064477NL-OMON33198Academisch Medisch Centrum20